These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38046278)

  • 21. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
    Yang L; Wang B; Qin J; Zhou H; Majumdar APN; Peng F
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):91-97. PubMed ID: 29303012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer.
    Guan Y; Zhang R; Peng Z; Dong D; Wei G; Wang Y
    J Bone Oncol; 2017 Nov; 9():59-64. PubMed ID: 29226090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.
    Yan F; Wang X; Xie Y; Liu X; Yu L; Wang P; Li T; Wang S; Li W; Yang Z
    Phytomedicine; 2021 Oct; 91():153722. PubMed ID: 34488188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
    Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS
    Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.
    Hammerich L; Tacke F
    World J Gastrointest Pathophysiol; 2015 Aug; 6(3):43-50. PubMed ID: 26301117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-β/CCL9 pathway.
    Tian S; Song X; Wang Y; Wang X; Mou Y; Chen Q; Zhao H; Ma K; Wu Z; Yu H; Han X; Wang H; Wang S; Ji X; Zhang Y
    Biomed Pharmacother; 2020 Sep; 129():110380. PubMed ID: 32554250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
    Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
    Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.
    Cao M; Xu Y; Youn JI; Cabrera R; Zhang X; Gabrilovich D; Nelson DR; Liu C
    Lab Invest; 2011 Apr; 91(4):598-608. PubMed ID: 21321535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response.
    Levy L; Mishalian I; Bayuch R; Zolotarov L; Michaeli J; Fridlender ZG
    Oncoimmunology; 2015 Apr; 4(4):e998469. PubMed ID: 26137413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer.
    Xu M; Zhao Z; Song J; Lan X; Lu S; Chen M; Wang Z; Chen W; Fan X; Wu F; Chen L; Tu J; Ji J
    Exp Cell Res; 2017 Feb; 351(2):142-149. PubMed ID: 28109867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients.
    Li X; Xing YF; Lei AH; Xiao Q; Lin ZH; Hong YF; Wu XY; Zhou J
    Oncotarget; 2017 Apr; 8(15):24380-24388. PubMed ID: 28412745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and differentiation of myeloid-derived suppressor cells after fluid resuscitation in mice with hemorrhagic shock.
    Jiang JK; Fang W; Hong LJ; Lu YQ
    J Zhejiang Univ Sci B; 2017 Jan.; 18(1):48-58. PubMed ID: 28070996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR2 agonist promotes myeloid-derived suppressor cell polarization via Runx1 in hepatocellular carcinoma.
    Li S; Li F; Xu L; Liu X; Zhu X; Gao W; Shen X
    Int Immunopharmacol; 2022 Oct; 111():109168. PubMed ID: 35998504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells.
    Zhao X; Sato A; Dela Cruz CS; Linehan M; Luegering A; Kucharzik T; Shirakawa AK; Marquez G; Farber JM; Williams I; Iwasaki A
    J Immunol; 2003 Sep; 171(6):2797-803. PubMed ID: 12960300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
    Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse CCL9 Chemokine Acts as Tumor Suppressor in a Murine Model of Colon Cancer.
    Łazarczyk M; Kurzejamska E; Mickael ME; Poznański P; Skiba D; Sacharczuk M; Gaciong Z; Religa P
    Curr Issues Mol Biol; 2023 Apr; 45(4):3446-3461. PubMed ID: 37185750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.